Shanghai People’s Procuratorate Launches Criminal Prosecution of Lego Block Infringers

Posted on Categories Case, Copyright

On February 26, 2020, the Third Branch of the Shanghai People’s Procuratorate launched a criminal prosecution against Li Moumou (李某某) and nine others for copyright infringement of Lego toys. From September 11, 2017 to April 23, 2019, Li Moumou and others produced and sold 634 types of infringing products with a volume of 4.24 million boxes and generating revenue of more than 300 million yuan (about $42.6 million USD). On April 23, 2019, public security organs seized more than 600,000 …

Chinese Patent Filings Show Uptick in January 2020

Posted on Categories Patents

The China National Intellectual Property Administration (CNIPA) recently released January 2020 intellectual property  statistics. There were 165,000 invention patent applications filed; 301,000 utility model patent applications filed; and 67,000 design patents filed.  Annualized, the invention patent statistics would indicate a 41% increase over 2019, in which 1.401 million invention patent applications were filed. However, this uptick is unlikely to continue due to COVID-19 related business closures in February 2020. CNIPA also granted 28,000 invention patents; 126,000 utility model patents; and …

China’s Supreme Court Rules in Favor of Christian Louboutin’s Red Sole Trademark

Posted on Categories Case, Trademarks

In January 2020, China’s Supreme People’s Court (最高人民法院) ruled in favor of Christian Louboutin for his red sole trademark.  The Supreme People’s Court decision upholds an earlier decision from Beijing Higher People’s Court that ruled even though single color marks are not listed as eligible in Article 8 of the Chinese Trademark, Article 8 does not exclude marks not enumerated in Article 8.  Specifically, Article 8 lists  combinations of colors as eligible for application but does not list a single …

Wuhan Institute of Virology Applies for a Patent on Gilead’s Remdesivir

Posted on Categories Patents

The Wuhan Institute of Virology announced on February 4, 2020 that they applied  for a Chinese patent on Gilead’s Remdesivir for treating the novel coronavirus (2019-nCoV) that originated in Wuhan in late 2019.  The Chinese patent application was filed on January 21, 2020 and the Institute plans to file internationally via the Patent Cooperation Treaty.